harmol has been researched along with Newcastle Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, J; Duan, L; Han, Y; Hou, Q; Hu, R; Li, N; Liu, H; Ren, S; Wang, C; Wang, J; Wang, T; Wang, W; Wang, X; Xiao, S; Yang, Z | 1 |
1 other study(ies) available for harmol and Newcastle Disease
| Article | Year |
|---|---|
9-Butyl-Harmol Exerts Antiviral Activity against Newcastle Disease Virus through Targeting GSK-3β and HSP90β.
Topics: Animals; Antiviral Agents; beta Catenin; Glycogen Synthase Kinase 3 beta; Harmine; HSP90 Heat-Shock Proteins; Humans; Newcastle Disease; Newcastle disease virus | 2023 |